Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23799
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKei, A.en
dc.contributor.authorFlorentin, M.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorLiberopoulos, E.en
dc.date.accessioned2015-11-24T19:36:04Z-
dc.date.available2015-11-24T19:36:04Z-
dc.identifier.issn1827-1839-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23799-
dc.rightsDefault Licence-
dc.subjectAdministration, Oralen
dc.subjectAnimalsen
dc.subjectAnticoagulants/administration & dosage/adverseen
dc.subjecteffects/pharmacokinetics/*therapeutic useen
dc.subjectAntithrombins/therapeutic useen
dc.subjectBlood Coagulation/*drug effectsen
dc.subjectFactor Xa/antagonists & inhibitorsen
dc.subjectHemorrhage/chemically induceden
dc.subjectHumansen
dc.subjectRisk Assessmenten
dc.titleAnticoagulant drugs: what is new?en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21747349-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2011-
heal.abstractHeparins and vitamin K antagonists have been the cornerstones of anticoagulation treatment for several decades. Despite their effectiveness, these agents have limitations which can include food and drug interactions and the need for monitoring. It follows that there is a need for new anticoagulants. There are numerous promising agents at various stages of evaluation. Those in the most advanced stages of development are the oral factor Xa and the thrombin inhibitors, which are the focus of this review.en
heal.journalNameInt Angiolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons